Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...

Researchers at UC San Francisco have developed a groundbreaking approach to treating Parkinson’s disease with a new type of brain implant called...

A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...

A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...

A new study from Beth Israel Deaconess Medical Center (BIDMC) has found that people with a history of damage to the lining of their upper...

A new study from Beth Israel Deaconess Medical Center (BIDMC) has found that people with a history of damage to the lining of their upper...

Athira's phase II/III LIFT-AD study on fosgonimeton for treating mild-to-moderate Alzheimer's disease fails to meet primary and secondary endpoints.

Athira's phase II/III LIFT-AD study on fosgonimeton for treating mild-to-moderate Alzheimer's disease fails to meet primary and secondary endpoints.

New research from the University of Kentucky’s Sanders-Brown Center on Aging has revealed that the cognitive impairments seen in long COVID patients...

Researchers from Karolinska Institutet have discovered how a common Parkinson’s disease treatment, levodopa, can lead to serious psychiatric issues...